Legionella infection associated with dimethyl fumarate used for treatment of multiple sclerosis

被引：0
|
作者：
Charlotte Rastas
David Sirignano
Amanda Barner
Lou Ann Bruno-Murtha
机构：
[1] Cambridge Health Alliance,Department of Medicine
[2] Cambridge Health Alliance,Department of Pharmacy
来源：
Journal of Neurology | 2019年 / 266卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2867 / 2868
页数：1
相关论文
共 50 条
  • [31] Dimethyl fumarate for treating relapsing multiple sclerosis
    Sheremata, William
    Brown, Andrew D.
    Rammohan, Kottil W.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 161 - 170
  • [32] Comparative effectiveness of dimethyl fumarate in multiple sclerosis
    Bosco-Levy, Pauline
    Debouverie, Marc
    Brochet, Bruno
    Guillemin, Francis
    Louapre, Celine
    Maillart, Elisabeth
    Heinzlef, Olivier
    Lignot, Severine
    Diez, Pauline
    Abouelfath, Abdelilah
    Lassalle, Regis
    Blin, Patrick
    Droz-Perroteau, Cecile
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1268 - 1278
  • [33] MULTIPLE SCLEROSIS Dimethyl fumarate is coming of age
    Tintore, Mar
    Sastre-Garriga, Jaume
    NATURE REVIEWS NEUROLOGY, 2016, 12 (08) : 436 - 437
  • [34] FACTORS ASSOCIATED WITH PRESCRIBING OF TERIFLUNOMIDE AND DIMETHYL FUMARATE VERSUS FINGOLIMOD IN MULTIPLE SCLEROSIS
    Earla, J. r
    Hutton, G. J.
    Aparasu, R. R.
    VALUE IN HEALTH, 2022, 25 (07) : S482 - S482
  • [35] Factors associated with dimethyl fumarate induced lymphopenia in a rural multiple sclerosis cohort
    Malik, M. T.
    Zhang, Y.
    Lee, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 572 - 572
  • [36] Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
    Ferri, Caterina
    Castellazzi, Massimiliano
    Merli, Nicola
    Laudisi, Michele
    Baldin, Elisa
    Baldi, Eleonora
    Mancabelli, Leonardo
    Ventura, Marco
    Pugliatti, Maura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [37] Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis
    Sattarnezhad, Neda
    Healy, Brian C.
    Baharnoori, Moogeh
    Diaz-Cruz, Camilo
    Stankiewicz, James
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [38] Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
    Vollmer, Brandi
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2016, 86
  • [39] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [40] Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
    Linker, Ralf A.
    Gold, Ralf
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
12345